Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 531 Squamous Cell Carcinoma of Head and Neck 273 Head and Neck Neoplasms 252 Lung Neoplasms 238 Uterine Cervical Neoplasms 176 Stomach Neoplasms 168 Esophageal Neoplasms 160 Nasopharyngeal Carcinoma 123 Urinary Bladder Neoplasms 116 Esophageal Squamous Cell Carcinoma 114 Neoplasms 113 Small Cell Lung Carcinoma 103 Breast Neoplasms 92 Ovarian Neoplasms 89 Neoplasm Metastasis 89 Carcinoma, Squamous Cell 76 Cholangiocarcinoma 75 Pancreatic Neoplasms 71 Biliary Tract Neoplasms 69 Mesothelioma, Malignant 57 Oropharyngeal Neoplasms 56 Carcinoma 55 Adenocarcinoma Of Esophagus 52 Recurrence 47 Parkinson Disease 4, Autosomal Dominant Lewy Body 47 Carcinoma, Ovarian Epithelial 45 Nasopharyngeal Neoplasms 41 Lymphoma 41 Adenocarcinoma of Lung 41 Gallbladder Neoplasms 38

Interventions

Nivolumab 5 Ipilimumab 3 relatlimab 1 daratumumab 1 Fluorouracil 1 Cisplatin 1 BMS-986115 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Various Advanced Cancer × Cisplatin × Clear all

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡